Last update at 2025-01-22T19:01:00Z
Here's Why We Think Hawkins (NASDAQ:HWKN) Might Deserve Your Attention Today
Mon 30 Dec 24, 03:44 PMWhat Does Hawkins, Inc.'s (NASDAQ:HWKN) Share Price Indicate?
Sun 15 Dec 24, 02:10 PMHawkins Insider Ups Holding During Year
Sun 01 Dec 24, 01:50 PMHawkins, Inc. (HWKN): A Bear Case Theory
Sat 30 Nov 24, 06:37 PMHawkins (NASDAQ:HWKN) Is Doing The Right Things To Multiply Its Share Price
Sun 17 Nov 24, 12:44 PMIs the Options Market Predicting a Spike in Hawkins (HWKN) Stock?
Mon 04 Nov 24, 04:23 PMHawkins, Inc. (NASDAQ:HWKN) Analysts Are Pretty Bullish On The Stock After Recent Results
Sun 03 Nov 24, 12:10 PM3 Reasons Growth Investors Will Love Hawkins (HWKN)
Mon 21 Oct 24, 04:45 PMBreakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Income before tax | 82.58M | 69.98M | 55.85M | 38.96M | 33.53M |
Minority interest | - | - | - | - | - |
Net income | 60.04M | 51.54M | 40.98M | 28.37M | 24.43M |
Selling general administrative | 76.97M | 75.33M | 67.88M | 59.25M | 59.12M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 165.12M | 146.52M | 123.76M | 100.92M | 95.94M |
Reconciled depreciation | 27.44M | 24.13M | 22.67M | 21.58M | 21.76M |
Ebit | 88.15M | 71.19M | 55.88M | 19.88M | 15.13M |
Ebitda | 115.26M | 95.51M | 79.99M | 41.47M | 36.89M |
Depreciation and amortization | 27.11M | 24.32M | 24.11M | 21.58M | 21.76M |
Non operating income net other | -0.33400M | 0.19M | 1.44M | -0.20400M | 0.07M |
Operating income | 88.15M | 71.19M | 55.88M | 19.88M | 33.46M |
Other operating expenses | 846.95M | 703.35M | 540.99M | 498.53M | 519.51M |
Interest expense | 5.23M | 1.40M | 1.47M | 2.51M | 3.36M |
Tax provision | 22.54M | 18.44M | 14.87M | 10.59M | 9.10M |
Interest income | - | - | - | - | 3.36M |
Net interest income | -5.23400M | -1.40400M | -1.46700M | -2.51100M | -3.36100M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 22.54M | 18.44M | 14.87M | 10.59M | 9.10M |
Total revenue | 935.10M | 774.54M | 596.87M | 540.20M | 556.33M |
Total operating expenses | 76.97M | 75.33M | 67.88M | 59.25M | 59.12M |
Cost of revenue | 769.98M | 628.02M | 473.11M | 439.28M | 460.39M |
Total other income expense net | -5.56800M | -1.21500M | -0.02700M | 19.07M | 18.39M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 60.04M | 51.54M | 40.98M | 28.37M | 24.43M |
Net income applicable to common shares | 60.04M | 51.54M | 40.98M | 28.37M | 24.43M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
Total assets | 673.16M | 590.53M | 567.33M | 472.55M | 389.33M |
Intangible assets | 116.63M | 73.06M | 80.19M | 76.37M | 60.65M |
Earning assets | - | - | - | - | - |
Other current assets | 6.60M | 6.45M | 6.43M | 5.37M | 4.93M |
Total liab | 267.13M | 240.52M | 264.73M | 207.30M | 155.84M |
Total stockholder equity | 406.03M | 350.02M | 302.60M | 265.25M | 233.48M |
Deferred long term liab | - | 23.80M | 23.42M | 24.45M | 25.11M |
Other current liab | 35.06M | 27.25M | 23.20M | 3.61M | 3.06M |
Common stock | 0.21M | 0.21M | 0.21M | 0.21M | 0.53M |
Capital stock | 0.21M | 0.21M | 0.21M | 0.21M | 0.53M |
Retained earnings | 364.55M | 302.42M | 254.38M | 213.90M | 182.95M |
Other liab | - | - | 38.47M | 37.77M | 36.22M |
Good will | 103.40M | 77.40M | 77.40M | 70.72M | 58.44M |
Other assets | 0.00000M | - | 7.78M | 6.21M | 3.77M |
Cash | 7.15M | 7.57M | 3.50M | 3.00M | 4.28M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 103.31M | 90.87M | 101.47M | 70.46M | 62.22M |
Current deferred revenue | 1.94M | - | - | 18.05M | 13.60M |
Net debt | 101.11M | 112.77M | 132.86M | 107.57M | 64.55M |
Short term debt | 9.91M | 9.91M | 11.57M | 11.49M | 11.43M |
Short long term debt | 9.91M | 9.91M | 9.91M | 9.91M | 9.91M |
Short long term debt total | 108.26M | 120.33M | 136.36M | 110.57M | 68.83M |
Other stockholder equity | 38.15M | 44.44M | 46.72M | 51.14M | 50.09M |
Property plant equipment | - | 185.80M | 161.85M | 156.24M | 126.34M |
Total current assets | 202.83M | 232.04M | 227.74M | 163.01M | 131.03M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | 350.02M | 302.60M | 118.16M | 233.48M |
Short term investments | - | - | - | - | - |
Net receivables | 114.48M | 129.25M | 122.83M | 90.78M | 67.39M |
Long term debt | 88.82M | 101.73M | 115.64M | 88.84M | 49.75M |
Inventory | 74.60M | 88.78M | 94.98M | 63.86M | 54.44M |
Accounts payable | 56.39M | 53.70M | 66.69M | 37.31M | 34.13M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 3.12M | 2.94M | 1.29M | -155.79200M | -0.07900M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | 0.21M | 0.21M | 0.21M | 0.53M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | 302.42M | 254.38M | 213.90M | 182.95M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 10.20M | -11.77200M | 9.54M | 6.21M | 3.77M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 470.33M | 358.49M | 339.59M | 309.54M | 258.30M |
Capital lease obligations | 9.53M | 8.69M | 10.80M | 11.82M | 9.17M |
Long term debt total | - | 101.73M | 115.64M | 88.84M | 49.75M |
Breakdown | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
Investments | -122.50400M | -41.23000M | -49.75600M | -71.43200M | -24.20300M |
Change to liabilities | - | -9.04300M | 28.07M | 2.55M | 5.48M |
Total cashflows from investing activities | - | -41.23000M | -49.75600M | -71.43200M | -24.20300M |
Net borrowings | - | -14.00000M | 26.71M | 39.00M | -25.00000M |
Total cash from financing activities | -37.40800M | -32.10000M | 7.42M | 26.36M | -39.62100M |
Change to operating activities | - | - | -2.19800M | 3.80M | -2.29500M |
Net income | 75.36M | 60.04M | 51.54M | 40.98M | 28.37M |
Change in cash | -0.41300M | 4.07M | 0.50M | -1.27900M | -4.92200M |
Begin period cash flow | 7.57M | 3.50M | 3.00M | 4.28M | 9.20M |
End period cash flow | 7.15M | 7.57M | 3.50M | 3.00M | 4.28M |
Total cash from operating activities | 159.50M | 77.40M | 42.84M | 43.79M | 58.90M |
Issuance of capital stock | 2.24M | 2.01M | 1.77M | 1.58M | 1.40M |
Depreciation | 31.80M | 27.44M | 24.13M | 22.67M | 21.58M |
Other cashflows from investing activities | - | 7.09M | -21.24400M | 0.36M | 0.35M |
Dividends paid | 13.24M | 12.00M | 11.06M | 10.03M | 9.82M |
Change to inventory | 19.92M | 4.72M | -30.03400M | -7.96000M | 6.04M |
Change to account receivables | 21.40M | -6.38900M | -30.52600M | -21.32300M | -3.38700M |
Sale purchase of stock | -11.27200M | -8.10700M | -10.01200M | -4.19400M | -6.19600M |
Other cashflows from financing activities | -2.14000M | 45.00M | 41.71M | 76.00M | 19.00M |
Change to netincome | - | 1.06M | 2.67M | 3.31M | 1.65M |
Capital expenditures | 40.15M | 48.32M | 28.51M | 20.79M | 24.55M |
Change receivables | - | -6.38900M | -30.52600M | -21.32300M | -3.38700M |
Cash flows other operating | - | -0.43000M | -3.02200M | -1.86000M | -0.92500M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | 4.07M | 0.50M | -1.27900M | -4.92200M |
Change in working capital | 47.02M | -13.11600M | -37.40600M | -23.16900M | 5.18M |
Stock based compensation | 4.88M | 3.83M | 3.82M | 3.34M | 2.27M |
Other non cash items | 29.88M | -0.55800M | 2.25M | 0.66M | 2.92M |
Free cash flow | 119.35M | 29.08M | 14.32M | 23.00M | 34.35M |
Sector: Basic Materials Industry: Specialty Chemicals
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
HWKN Hawkins Inc |
1.83 1.58% | 117.72 | 24.42 | 21.05 | 1.75 | 4.10 | 1.88 | 13.02 |
LIN Linde plc Ordinary Shares |
3.50 0.79% | 445.96 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
AIQUF L'Air Liquide S.A |
- -% | 167.93 | 29.39 | 24.69 | 3.41 | 3.97 | 3.87 | 15.91 |
AIQUY Air Liquide SA ADR |
0.16 0.48% | 33.70 | 30.34 | 23.04 | 3.63 | 3.77 | 3.88 | 15.62 |
SHW Sherwin-Williams Co |
-4.27 1.18% | 357.25 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Hawkins, Inc. operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products, such as liquid phosphates, lactates, other blended products, and agricultural products; and receives, stores, and distributes various chemicals comprising liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. The Water Treatment segment provides chemicals, products, equipment, services, and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, vitamins and amino acids, excipients, joint products, botanicals and herbs, sweeteners, and enzymes. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.
2381 Rosegate, Roseville, MN, United States, 55113
Name | Title | Year Born |
---|---|---|
Mr. Patrick H. Hawkins | CEO, Pres & Director | 1971 |
Mr. Jeffrey P. Oldenkamp | Exec. VP, CFO & Treasurer | 1972 |
Mr. Drew M. Grahek | VP of Operations | 1971 |
Mr. Richard G. Erstad | VP, Gen. Counsel & Sec. | 1964 |
Mr. Daniel J. Stauber | Director | 1962 |
Ms. Shirley A. Rozeboom | VP of Health & Nutrition | 1962 |
Mr. Paul Siler | Corp. Controller | NA |
Mr. Patrick H. Hawkins | CEO, President & Director | 1971 |
Mr. Jeffrey P. Oldenkamp | Executive VP, CFO & Treasurer | 1972 |
Mr. Drew M. Grahek | Vice President of Operations | 1971 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.